GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $12,000 | -14.3% | 32,071 | +11.8% | 0.00% | – |
Q2 2016 | $14,000 | -93.6% | 28,686 | -82.1% | 0.00% | – |
Q1 2016 | $218,000 | +144.9% | 160,251 | +166.6% | 0.00% | – |
Q4 2015 | $89,000 | +456.2% | 60,108 | +487.8% | 0.00% | – |
Q3 2015 | $16,000 | -23.8% | 10,226 | -16.9% | 0.00% | – |
Q2 2015 | $21,000 | -19.2% | 12,301 | -33.1% | 0.00% | – |
Q1 2015 | $26,000 | -43.5% | 18,398 | -39.7% | 0.00% | – |
Q4 2014 | $46,000 | +58.6% | 30,535 | +111.6% | 0.00% | – |
Q3 2014 | $29,000 | -62.3% | 14,433 | -42.5% | 0.00% | – |
Q2 2014 | $77,000 | +6.9% | 25,105 | -12.0% | 0.00% | – |
Q1 2014 | $72,000 | -74.1% | 28,516 | -49.1% | 0.00% | – |
Q4 2013 | $278,000 | +1637.5% | 56,055 | +666.7% | 0.00% | – |
Q3 2013 | $16,000 | – | 7,311 | +3555.5% | 0.00% | – |
Q2 2013 | $0 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
Matisse Capital | 17,000 | $25,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |